- Home
- EVTC vs BCRX Comparison
EVTC vs BCRX Comparison
Compare EVTC & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVTC
- BCRX
- Stock Information
- Founded
- EVTC 1988
- BCRX 1986
- Country
- EVTC United States
- BCRX United States
- Employees
- EVTC N/A
- BCRX N/A
- Industry
- EVTC EDP Services
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EVTC Technology
- BCRX Health Care
- Exchange
- EVTC Nasdaq
- BCRX Nasdaq
- Market Cap
- EVTC 2.1B
- BCRX 1.9B
- IPO Year
- EVTC 2013
- BCRX 1994
- Fundamental
- Price
- EVTC $35.70
- BCRX $8.30
- Analyst Decision
- EVTC Hold
- BCRX Strong Buy
- Analyst Count
- EVTC 5
- BCRX 10
- Target Price
- EVTC $39.00
- BCRX $16.70
- AVG Volume (30 Days)
- EVTC 388.1K
- BCRX 3.7M
- Earning Date
- EVTC 07-30-2025
- BCRX 08-04-2025
- Dividend Yield
- EVTC 0.56%
- BCRX N/A
- EPS Growth
- EVTC 102.95
- BCRX N/A
- EPS
- EVTC 2.13
- BCRX N/A
- Revenue
- EVTC $886,589,000.00
- BCRX $557,506,000.00
- Revenue This Year
- EVTC $7.87
- BCRX $37.96
- Revenue Next Year
- EVTC $5.05
- BCRX $8.82
- P/E Ratio
- EVTC $16.74
- BCRX N/A
- Revenue Growth
- EVTC 12.93
- BCRX 45.85
- 52 Week Low
- EVTC $31.11
- BCRX $6.02
- 52 Week High
- EVTC $38.56
- BCRX $11.31
- Technical
- Relative Strength Index (RSI)
- EVTC 56.48
- BCRX 42.73
- Support Level
- EVTC $34.19
- BCRX $7.91
- Resistance Level
- EVTC $36.75
- BCRX $8.65
- Average True Range (ATR)
- EVTC 0.70
- BCRX 0.32
- MACD
- EVTC 0.31
- BCRX 0.05
- Stochastic Oscillator
- EVTC 73.74
- BCRX 31.71
About EVTC Evertec Inc.
Evertec Inc is a transaction processing business in Latin America and the Caribbean. Its business segments are Merchant Acquiring, Payment Services - Puerto Rico & Caribbean, Latin America Payments and Solutions, and Business Solutions which derive maximum revenue. The company serves a diversified customer base of financial institutions, merchants, corporations, and government agencies with mission-critical technology solutions that enable them to issue, process, and accept transactions securely. It derives maximum revenue from Latin America Payments and Solutions. Geographically, it operates in Puerto Rico, Caribbean, and Latin America.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.